Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Orthopediatrics Corp(KIDS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for KIDS
10/23/2026: KIDS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
OrthoPediatrics Corp. is a specialized medical device company exclusively focused on the pediatric orthopedic market. Its primary strength lies in providing age-appropriate implants and surgical instruments, building strong relationships with surgeons and maintaining a distinctive brand niche. The main investment story centers on the company’s ability to grow within an underserved market, fueled by new technology and international expansion. Risks include high valuation, price volatility, and the potential for larger competitors to target its niche. The stock is best suited for growth-oriented investors who can tolerate volatility and should monitor the successful integration of acquisitions and international revenue scaling.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company is in an active expansion phase within a niche, high-barrier medical device market. |
| Momentum investor | Mixed fit | Momentum depends on specific technical breakouts and sustained revenue growth news. |
| Value investor | Weak fit | The stock often trades at high multiples relative to current earnings due to its growth-oriented nature. |
| Dividend investor | Weak fit | The company does not pay a dividend, favoring capital reinvestment. |
| Low-risk investor | Weak fit | Small-cap medical device stocks typically experience higher price volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | As a small-cap growth stock, KIDS is subject to significant swings in market sentiment. |
| Valuation risk | Medium / high | High P/E or growth premiums can lead to sharp corrections if revenue growth slows. |
| Competition risk (Adult-focused incumbents) | Medium | Large incumbents could potentially focus more resources on the pediatric segment. |
| Business quality | Medium | The company has a strong niche franchise but lacks the scale and diversification of peers. |
| Dividend income | Low / none | Investors should not expect income from this equity. |
| Execution risk | Medium | Success relies heavily on integrating acquisitions and maintaining sales force productivity. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -36.96% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 639.69M USD | Price to earnings Ratio - | 1Y Target Price 27.5 |
Price to earnings Ratio - | 1Y Target Price 27.5 | ||
Volume (30-day avg) 206.6K shares | Beta 0.99 | 52 Weeks Range 14.42 - 26.74 | Updated Date 10/24/2026 |
52 Weeks Range 14.42 - 26.74 | Updated Date 10/24/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.68 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Trauma & Deformity | Sale of bone plates, screws, and hardware for pediatric fractures. | This is the core revenue driver providing consistent demand for trauma-related surgeries. |
| Scoliosis | Advanced spinal implants and navigation systems like Firefly. | This segment offers higher-margin, technology-driven growth opportunities. |
| International | Direct and distributor sales of the product portfolio globally. | Geographic expansion is a key pillar for future scale and revenue diversification. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 476.59M | Price to Sales(TTM) 2.53 |
Enterprise Value 476.59M | Price to Sales(TTM) 2.53 | ||
Enterprise Value to Revenue 2.16 | Enterprise Value to EBITDA 48.54 | Shares Outstanding 26.11M | Shares Floating 18.22M |
Shares Outstanding 26.11M | Shares Floating 18.22M | ||
Percent Insiders 29.7 | Percent Institutions 65.82 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.